Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96LA9: Variant p.Asn245Ser

Mas-related G-protein coupled receptor member X4
Gene: MRGPRX4
Feedback?
Variant information Variant position: help 245 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Asparagine (N) to Serine (S) at position 245 (N245S, p.Asn245Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (N) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help Found in persons of African ancestry; associated with increased preference for mentholated cigarettes among smokers; reduced activation by agonists. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 245 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 322 The length of the canonical sequence.
Location on the sequence: help FLLCGLPFGILGALIYRMHL N LEVLYCHVYLVCMSLSSLNS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 322 Mas-related G-protein coupled receptor member X4
Topological domain 239 – 249 Extracellular
Disulfide bond 23 – 251
Mutagenesis 232 – 232 F -> A. Decreased binding to 3-sulfated bile acids.
Mutagenesis 235 – 235 L -> A. Reduced affinity for deoxycholate and 3-sulfated bile acids.
Mutagenesis 240 – 240 Y -> A. Decreased binding to 3-sulfated bile acids. Decreased activation by agonists.
Mutagenesis 241 – 241 R -> A. Decreased binding to 3-sulfated bile acids.
Mutagenesis 250 – 250 Y -> A. Decreased activation by phosphate-modified drugs, such as fospropofol.
Mutagenesis 254 – 254 Y -> A. Decreased activation by phosphate-modified drugs, such as fospropofol.



Literature citations
An African-specific haplotype in MRGPRX4 is associated with menthol cigarette smoking.
Kozlitina J.; Risso D.; Lansu K.; Olsen R.H.J.; Sainz E.; Luiselli D.; Barik A.; Frigerio-Domingues C.; Pagani L.; Wooding S.; Kirchner T.; Niaura R.; Roth B.; Drayna D.;
PLoS Genet. 15:e1007916-e1007916(2019)
Cited for: FUNCTION; ACTIVITY REGULATION; VARIANT SER-245; CHARACTERIZATION OF VARIANT SER-245;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.